ACRV
Price
$1.98
Change
+$0.02 (+1.02%)
Updated
Jul 13 closing price
Capitalization
84.96M
36 days until earnings call
Intraday BUY SELL Signals
IMRX
Price
$5.16
Change
+$0.05 (+0.98%)
Updated
Jul 13 closing price
Capitalization
334.49M
29 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACRV vs IMRX

ACRV vs IMRX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACRV vs. IMRX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a Hold and IMRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (ACRV: $1.98 vs. IMRX: $5.16)
Brand notoriety: ACRV and IMRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 148% vs. IMRX: 22%
Market capitalization -- ACRV: $84.96M vs. IMRX: $334.49M
ACRV [@Biotechnology] is valued at $84.96M. IMRX’s [@Biotechnology] market capitalization is $334.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileIMRX’s FA Score has 0 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • IMRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACRV is a better buy in the long-term than IMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 6 TA indicator(s) are bullish while IMRX’s TA Score has 6 bullish TA indicator(s).

  • ACRV’s TA Score: 6 bullish, 4 bearish.
  • IMRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ACRV and IMRX are a good buy in the short-term.

Price Growth

ACRV (@Biotechnology) experienced а +11.24% price change this week, while IMRX (@Biotechnology) price change was +0.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

ACRV is expected to report earnings on Aug 19, 2026.

IMRX is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMRX($334M) has a higher market cap than ACRV($85M). ACRV YTD gains are higher at: -17.842 vs. IMRX (-21.581). IMRX has higher annual earnings (EBITDA): -63.82M vs. ACRV (-80.93M). IMRX has more cash in the bank: 157M vs. ACRV (97.7M). ACRV has less debt than IMRX: ACRV (2.42M) vs IMRX (3.73M). ACRV (0) and IMRX (0) have equivalent revenues.
ACRVIMRXACRV / IMRX
Capitalization85M334M25%
EBITDA-80.93M-63.82M127%
Gain YTD-17.842-21.58183%
P/E RatioN/AN/A-
Revenue00-
Total Cash97.7M157M62%
Total Debt2.42M3.73M65%
TECHNICAL ANALYSIS
Technical Analysis
ACRVIMRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 12 days ago
88%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signal:
Gain/Loss:
IMRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FICEX15.19N/A
N/A
Frost Growth Equity Inst
OALVX21.70N/A
N/A
Optimum Large Cap Value A
OEGNX28.47N/A
N/A
Invesco Discovery Mid Cap Growth R
IARYX18.17N/A
N/A
Invesco Real Estate Y
TANDX31.58N/A
N/A
Tandem Fund

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
+1.02%
ALLR - ACRV
48%
Loosely correlated
-3.00%
CRMD - ACRV
41%
Loosely correlated
-0.95%
DNA - ACRV
39%
Loosely correlated
-0.44%
RAPP - ACRV
36%
Loosely correlated
-2.78%
IMRX - ACRV
35%
Loosely correlated
+0.98%
More

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with SPRB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
+0.98%
SPRB - IMRX
52%
Loosely correlated
-3.38%
CRMD - IMRX
38%
Loosely correlated
-0.95%
SION - IMRX
34%
Loosely correlated
-2.96%
ACRV - IMRX
34%
Loosely correlated
+1.02%
KURA - IMRX
32%
Poorly correlated
-4.72%
More